Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Favorable Resuls After Primed G-CSF BMT (G-BMT) for Patients (pts) with Severe Aplastic Anemia (SAA) Conditioning with Buslfan (Bu), Cyclophosphamide (Cy) and Rabbit ATG Using Mycophenolate Mofetil (MMF) and Cyclosporine-A (CSA) for Gvhd Prophylaxis: Rapid Neutrophil Engraftment, Low Rejection Rate and Chronic Gvhd .

Mauricio Ostronoff, MD, ANA Patricia Souto Maior, Rodolfo Calixto, Fabiana Ostronoff, MD, Rodrigo Florencio, MD, Monique Martins, Luis Fabio Botelho, Alexandre Sucupira, Mariana Coutinho

Blood (2010) 116 (21): 1279.

https://doi.org/10.1182/blood.V116.21.1279.1279

Published: 2010

Journal Articles

Alemtuzumab for Treatment of Acute Gvhd In Steroid-Refractory Patients .

Alexandre Sucupira, Mauricio Ostronoff, MD, Fabiana Ostronoff, MD, ANA Patricia Souto Maior, Jose Carlos Freitas, Rodrigo Florencio, MD, Luis Fabio Botelho, Monique Martins, Rodolfo Calixto

Blood (2010) 116 (21): 4545.

https://doi.org/10.1182/blood.V116.21.4545.4545

Published: 2010

Journal Articles

Autologous SCT In Patients (pts) with Chemotherapy-Resistant Diffuse Large B Cell Lymphoma (DLBCL) Followed by Maintenance with Rituximab .

Rodolfo Calixto, Mauricio Ostronoff, MD, Fabiana Ostronoff, MD, Alexandre Sucupira, Djenane Manso, ANA Patricia Souto Maior, Rodrigo Florencio, MD, Monique Martins, Luis Fabio Botelho, Mariana Coutinho

Blood (2010) 116 (21): 4598.

https://doi.org/10.1182/blood.V116.21.4598.4598

Published: 2010

Journal Articles

Favorable Results After GCSF-Primed Allogeneic BMT for Children with Severe Aplastic Anemia Using Busulfan, Cyclophosphamide and ATG as Conditioning Regimen and Cyclosporine-A and Micofenolate Mofetil as Graft-Versus-Host-Disease Prophylaxys: Rapid Engraftment, Low Incidence of Chronic Gvhd and Reduced Graft Rejection Rates.

Mauricio Ostronoff, MD, Fabiana Ostronoff, MD, Rodolfo Calixto, Alexandre Sucupira, Manuela Gomes, Rodrigo Florencio, MD, Monique Martins, ANA Patricia Souto Maior

Blood (2010) 116 (21): 3489.

https://doi.org/10.1182/blood.V116.21.3489.3489

Published: 2010

Journal Articles

G-CSF-Primed Allogeneic-BMT Following Reduced Intensity Conditioning (RIC) Regimen for Patients with AML. Rapid Engraftment, Low Incidence of Chronic Gvhd (cGVHD) and Good Outcome for Patients In 1 st Complete Remission (CR), but Not for More Advanced Cases

Mauricio Ostronoff, MD, ANA Patricia Souto Maior, Fabiana Ostronoff, MD, Rodrigo Florencio, MD, Monique Martins, Luis Fabio Botelho, Alexandre Sucupira, Mariana Coutinho, Rodolfo Calixto

Blood (2010) 116 (21): 3521.

https://doi.org/10.1182/blood.V116.21.3521.3521

Published: 2010

Journal Articles

Primed-G-CSF BMT for Children with Fanconi Anemia (FA) Using Mycophenolate Mofetil (MMF) and Cyclosporine-A for Gvhd Prophylaxis: Rapid Neutrophil Engraftment, Less Mucositis and Low Incidence of Chronic Gvhd

Fabiana Ostronoff, MD, Mauricio Ostronoff, MD, ANA Patricia Souto Maior, Rodolfo Calixto, Monique Martins, Mariana Coutinho, Alexandre Sucupira, Luis Fabio Botelho, Rodrigo Florencio, MD

Blood (2010) 116 (21): 3522.

https://doi.org/10.1182/blood.V116.21.3522.3522

Published: 2010

Journal Articles

GCSF-Primed Allo-BMT Following Reduced Intensity Conditioning Regimen In Children with AML- Good Outcome In Patients In 1 st Complete Remission with Rapid Neutrophil Engraftment and Low Incidence of Chronic Gvhd .

Fabiana Ostronoff, MD, Mauricio Ostronoff, MD, ANA Patricia Souto Maior, Rodolfo Calixto, Monique Martins, Mariana Coutinho, Alexandre Sucupira, Luis Fabio Botelho, Rodrigo Florencio, MD

Blood (2010) 116 (21): 4566.

https://doi.org/10.1182/blood.V116.21.4566.4566

Published: 2010

Journal Articles

Primed-GCSF BMT Following Reduced Intensity Conditioning Regimen (RIC) for Patients (pts) with Poor-Prognosis, Heavily Pre-Treated, Hodgkin's Disease (HD).

Rodolfo Calixto, Mauricio Ostronoff, MD, Fabiana Ostronoff, MD, Djenane Manso, ANA Patricia Souto Maior, Alexandre Sucupira, Rodrigo Florencio, MD, Monique Martins, Luis Fabio Botelho, Mariana Coutinho

Blood (2010) 116 (21): 1312.

https://doi.org/10.1182/blood.V116.21.1312.1312

Published: 2010

Journal Articles

Primed-GCSF BMT After Reduced Intensity Conditioning (RIC) In Association with Rituximab for Patients (pts) with Refractory CD20+ Aggressive Lymphomas..

Rodolfo Calixto, Fabiana Ostronoff, MD, Mauricio Ostronoff, MD, Alexandre Sucupira, Djenane Manso, ANA Patricia Souto Maior, Rodrigo Florencio, MD, Monique Martins, Luis Fabio Botelho, Mariana Coutinho

Blood (2010) 116 (21): 1313.

https://doi.org/10.1182/blood.V116.21.1313.1313

Published: 2010

NARROW

Alemtuzumab for Treatment of Acute Gvhd In Steroid-Refractory Patients .

Autologous SCT In Patients (pts) with Chemotherapy-Resistant Diffuse Large B Cell Lymphoma (DLBCL) Followed by Maintenance with Rituximab .

G-CSF-Primed Allogeneic-BMT Following Reduced Intensity Conditioning (RIC) Regimen for Patients with AML. Rapid Engraftment, Low Incidence of Chronic Gvhd (cGVHD) and Good Outcome for Patients In 1 st Complete Remission (CR), but Not for More Advanced Cases

Primed-G-CSF BMT for Children with Fanconi Anemia (FA) Using Mycophenolate Mofetil (MMF) and Cyclosporine-A for Gvhd Prophylaxis: Rapid Neutrophil Engraftment, Less Mucositis and Low Incidence of Chronic Gvhd

GCSF-Primed Allo-BMT Following Reduced Intensity Conditioning Regimen In Children with AML- Good Outcome In Patients In 1 st Complete Remission with Rapid Neutrophil Engraftment and Low Incidence of Chronic Gvhd .

Primed-GCSF BMT Following Reduced Intensity Conditioning Regimen (RIC) for Patients (pts) with Poor-Prognosis, Heavily Pre-Treated, Hodgkin's Disease (HD).

Primed-GCSF BMT After Reduced Intensity Conditioning (RIC) In Association with Rituximab for Patients (pts) with Refractory CD20+ Aggressive Lymphomas..

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only